The aim of this retrospective study was to determine the risk factors for progression of CKD in patients with biopsy-proven NAFLD including patatin-like phospholipase domain containing 3 (PNPLA3) polymorphism. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.